Terms: = Thyroid cancer AND JUN, P05412, 3725, ENSG00000177606, AP1, c-Jun AND Prognosis
20 results:
1. Network Pharmacological Analysis and Experimental Validation of the Effects of Silybin on Proliferation, Migration, and Immunotherapy of Papillary thyroid cancer.
Xie W; Li H; Lin Q; Ke N
Endocr Metab Immune Disord Drug Targets; 2024; 24(6):672-690. PubMed ID: 37855349
[TBL] [Abstract] [Full Text] [Related]
2. Targeting c-jun inhibits fatty acid oxidation to overcome tamoxifen resistance in estrogen receptor-positive breast cancer.
Jiang C; Zhu Y; Chen H; Lin J; Xie R; Li W; Xue J; Chen L; Chen X; Xu S
Cell Death Dis; 2023 Oct; 14(10):653. PubMed ID: 37803002
[TBL] [Abstract] [Full Text] [Related]
3. Icariin Induces Triple-Negative Breast cancer Cell Apoptosis and Suppresses Invasion by Inhibiting the JNK/c-jun Signaling Pathway.
Gao S; Zhang X; Liu J; Ji F; Zhang Z; Meng Q; Zhang Q; Han X; Wu H; Yin Y; Lv Y; Shi W
Drug Des Devel Ther; 2023; 17():821-836. PubMed ID: 36969705
[TBL] [Abstract] [Full Text] [Related]
4. N6-Methyladenosine-Mediated Up-Regulation of FZD10 Regulates Liver cancer Stem Cells' Properties and Lenvatinib Resistance Through WNT/β-Catenin and Hippo Signaling Pathways.
Wang J; Yu H; Dong W; Zhang C; Hu M; Ma W; Jiang X; Li H; Yang P; Xiang D
Gastroenterology; 2023 May; 164(6):990-1005. PubMed ID: 36764493
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic significance of SHP2 (PTPN11) expression in solid tumors: A meta-analysis.
Zhou J; Guo H; Zhang Y; Liu H; Dou Q
PLoS One; 2022; 17(1):e0262931. PubMed ID: 35061863
[TBL] [Abstract] [Full Text] [Related]
6. The initial expression alterations occurring to transcription factors during the formation of breast cancer: Evidence from bioinformatics.
Dong X; Yang Y; Xu G; Tian Z; Yang Q; Gong Y; Wu G
Cancer Med; 2022 Mar; 11(5):1371-1395. PubMed ID: 35037412
[TBL] [Abstract] [Full Text] [Related]
7. Systems biomarkers for papillary thyroid cancer prognosis and treatment through multi-omics networks.
Gulfidan G; Soylu M; Demirel D; Erdonmez HBC; Beklen H; Ozbek Sarica P; Arga KY; Turanli B
Arch Biochem Biophys; 2022 Jan; 715():109085. PubMed ID: 34800440
[TBL] [Abstract] [Full Text] [Related]
8. Ultrasound features of medullary thyroid cancer as predictors of biological behavior.
Zhao J; Zheng X; Gao M; Zhang S; Yun X; Chi J; Xu G
Cancer Imaging; 2021 Apr; 21(1):33. PubMed ID: 33836831
[TBL] [Abstract] [Full Text] [Related]
9. TFAP2B, AP-1 and JAZF1 Expression in Tissues of Papillary thyroid Carcinoma Patients; Clinical, Pathological and Prognostic Values.
A Abuderman A; A Harb O; M Gertallah L; Makki Almansour N
Asian Pac J Cancer Prev; 2020 Aug; 21(8):2415-2421. PubMed ID: 32856873
[TBL] [Abstract] [Full Text] [Related]
10. Identification of an ap1-ZFP36 Regulatory Network Associated with Breast cancer prognosis.
Canzoneri R; Naipauer J; Stedile M; Rodriguez Peña A; Lacunza E; Gandini NA; Curino AC; Facchinetti MM; Coso OA; Kordon E; Abba MC
J Mammary Gland Biol Neoplasia; 2020 Jun; 25(2):163-172. PubMed ID: 32248342
[TBL] [Abstract] [Full Text] [Related]
11. The significance of Runx2 mediating alcohol-induced Brf1 expression and RNA Pol III gene transcription.
Hong Z; Fang Z; Lei J; Shi G; Zhang Y; He Z; Li B W; Zhong S
Chem Biol Interact; 2020 May; 323():109057. PubMed ID: 32198086
[TBL] [Abstract] [Full Text] [Related]
12. ATR-FTIR spectroscopy and CDKN1C gene expression in the prediction of lymph nodes metastases in papillary thyroid carcinoma.
da Silva RM; Pupin B; Bhattacharjee TT; Vamondes Kulcsar MA; Uno M; Chammas R; de Azevedo Canevari R
Spectrochim Acta A Mol Biomol Spectrosc; 2020 Mar; 228():117693. PubMed ID: 31708464
[TBL] [Abstract] [Full Text] [Related]
13. Oncofetal HLF transactivates c-jun to promote hepatocellular carcinoma development and sorafenib resistance.
Xiang DM; Sun W; Zhou T; Zhang C; Cheng Z; Li SC; Jiang W; Wang R; Fu G; Cui X; Hou G; Jin GZ; Li H; Hou C; Liu H; Wang H; Ding J
Gut; 2019 Oct; 68(10):1858-1871. PubMed ID: 31118247
[TBL] [Abstract] [Full Text] [Related]
14. Gene expression differences between thyroid carcinoma, thyroid adenoma and normal thyroid tissue.
Wang Q; Shen Y; Ye B; Hu H; Fan C; Wang T; Zheng Y; Lv J; Ma Y; Xiang M
Oncol Rep; 2018 Dec; 40(6):3359-3369. PubMed ID: 30272326
[TBL] [Abstract] [Full Text] [Related]
15. Activator Protein-2β Promotes Tumor Growth and Predicts Poor prognosis in Breast cancer.
Li Z; Xu X; Luo M; Hao J; Zhao S; Yu W; Xiao X; Wu J; Zheng F; Chen M; Li Y; Qin G; Liao Y; Zhao X; Yu X; Guo W; Zou L; Deng W
Cell Physiol Biochem; 2018; 47(5):1925-1935. PubMed ID: 29972820
[TBL] [Abstract] [Full Text] [Related]
16. Role of the TGFβ/PDCD4/AP-1 Signaling Pathway in Nasopharyngeal Carcinoma and Its Relationship to prognosis.
Ma J; Xuan SH; Li Y; Zhang ZP; Li XH
Cell Physiol Biochem; 2017; 43(4):1392-1401. PubMed ID: 29017171
[TBL] [Abstract] [Full Text] [Related]
17. Risk Factors for Nodal Metastasis in cN0 Papillary thyroid Microcarcinoma.
Zhang LY; Liu ZW; Liu YW; Gao WS; Zheng CJ
Asian Pac J Cancer Prev; 2015; 16(8):3361-3. PubMed ID: 25921145
[TBL] [Abstract] [Full Text] [Related]
18. [Prognostic factors affecting results of comprehensive treatment of hypopharyngeal carcinoma].
Xu W; Lyu Z; Yang Z; Zou J; Cao H
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jul; 49(7):533-8. PubMed ID: 25257265
[TBL] [Abstract] [Full Text] [Related]
19. Lymph node ratio is more predictive than traditional lymph node stratification in lymph node positive invasive breast cancer.
Bai LS; Chen C; Gong YP; Wei W; Tu Y; Yao F; Li JJ; Wang LJ; Sun SR
Asian Pac J Cancer Prev; 2013; 14(2):753-7. PubMed ID: 23621232
[TBL] [Abstract] [Full Text] [Related]
20. FRA-1 protein overexpression is a feature of hyperplastic and neoplastic breast disorders.
Chiappetta G; Ferraro A; Botti G; Monaco M; Pasquinelli R; Vuttariello E; Arnaldi L; Di Bonito M; D'Aiuto G; Pierantoni GM; Fusco A
BMC Cancer; 2007 Jan; 7():17. PubMed ID: 17254320
[TBL] [Abstract] [Full Text] [Related]
